Beacon Trusteeship Regulatory Approval

Employee Stock Options

Beacon Trusteeship Employee Stock Options

Beacon Trusteeship Limited has granted 50,500 Employee Stock Options to eligible employees under the BTL ESOP Plan 2025.

Other Announcement

Beacon Trusteeship Other Announcement

Beacon Trusteeship Limited informed the exchange that Corporate Governance provisions are not applicable to the company for the quarter ended September 30, 2026.

Regulatory ApprovalAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Beacon Trusteeship Regulatory Approval

Beacon Trusteeship's subsidiary, Beacon Investor Holdings, received SEBI approval to operate as a trading member on the Metropolitan Stock Exchange (MSEIL).

Employee Stock Options

Beacon Trusteeship Employee Stock Options

Beacon Trusteeship Limited has allotted 28,000 equity shares under its ESOP Plan 2025. This allotment increases the company's total issued and subscribed share capital to 1,80,92,913 shares.

Value

₹0.17 Cr

Other Announcement

Beacon Trusteeship Other Announcement

Beacon Trusteeship Limited's board approved amending its Memorandum of Association to expand its business scope. This enables potential future entry into new financial services segments.

Merger & Restructuring

Beacon Trusteeship Merger & Restructuring Worth ₹0.25 Cr

Beacon Trusteeship Limited is incorporating a Wholly Owned Subsidiary in Dubai for financial services. The investment for this expansion is approximately INR 25 Lakhs (0.25 Crore).

Value

₹0.25 Cr

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.